4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001415889-25-018128
Chief Financial Officer sold 33,500 shares at an average $10.49 ($351,384)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Piscitelli Dominic Chief Financial Officer | 2025-06-23 | Sale 10b5-1 | −584 | $10.00 | $5,840 | 101,233 | D |
| Piscitelli Dominic Chief Financial Officer | 2025-06-23 | Sale 10b5-1 | −450 | $10.01 | $4,505 | 100,783 | D |
| Piscitelli Dominic Chief Financial Officer | 2025-06-24 | Sale 10b5-1 | −32,466 | $10.50 | $341,039 | 68,317 | D |
| Open-market sales · 33,500 sh · avg $10.49 · $351,384 | |||||||
Loading xslF345X05/form4-06242025_100608.xml…